Trends in the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists among ischemic stroke patients. - Ding Q; Sico JJ; Perkins AJ; Myers LJ; Daggy JK; Sexson A; Taylor SE; Burrone L; Waddell K; Bravata DM (Cardiovascular diabetology. Endocrinology reports, 2026)